Ammonia was CF Industries Holdings’s largest segment in fiscal 2025, bringing in $2.18B of $5.30B (41%).
| Segment | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Uan | $3.57B | $2.07B | $1.68B | $2.16B | |||||||||||||
| Ammonia | $3.09B | $1.68B | $1.74B | $2.18B | |||||||||||||
| Salesrevenuenet | — | — | — | — | |||||||||||||
| Revenue, Net | — | — | — | — | |||||||||||||
| Net Sales | — | — | — | — | |||||||||||||
| Urea | — | $56.00M | $72.00M | — | |||||||||||||
| Granular Urea | $170.00M | — | — | — | |||||||||||||
| Phosphate | — | — | — | — | |||||||||||||
| Other | $787.00M | $564.00M | $503.00M | $545.00M | |||||||||||||
| An | $845.00M | $497.00M | $419.00M | $421.00M | |||||||||||||
| Other Products | — | — | — | — | |||||||||||||
| Total | $8.46B | $4.86B | $4.41B | $5.30B |
CF Industries Holdings brought in $5.30B from its four segments in fiscal 2025, the year ended December 31, 2025. CF Industries Holdings regrouped these segments after fiscal 2024, so the total does not compare directly with that year's $4.41B. Ammonia was the largest at $2.18B (41.0%), ahead of Uan at $2.16B (40.8%) and Other at $545.00M (10.3%). The remaining segment, An, brought in $421.00M.
Compared with fiscal 2024, Uan grew fastest, up 28.8% to $2.16B. Every segment above 2% of revenue grew.
CF Industries Holdings stopped reporting Granular Urea ($170.00M in fiscal 2022) and Urea ($72.00M in fiscal 2024) as separate segments.
United States was CF Industries Holdings’s largest region in fiscal 2017, bringing in $2.85B of $4.18B (68%).
| Geography | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| United States | $3.99B | $3.49B | $2.73B | $2.85B | |||||
| U.S | — | — | — | — | |||||
| Salesrevenuenet | — | — | — | — | |||||
| Revenue, Net | — | — | — | — | |||||
| Net Sales | — | — | — | — | |||||
| United Kingdom | — | $153.00M | $394.00M | $427.00M | |||||
| Canada | $544.00M | $490.00M | $349.00M | $352.00M | |||||
| Other Foreign | $205.00M | $180.00M | $214.00M | $500.00M | |||||
| Export | — | — | — | — | |||||
| North America Excluding United States & Canada | — | — | $24.00M | $50.00M | |||||
| Total | $4.74B | $4.31B | $3.71B | $4.18B |
CF Industries Holdings brought in $4.18B from its five regions in fiscal 2017, the year ended December 31, 2017. That was up 12.7% from $3.71B in fiscal 2016. United States was the largest at $2.85B (68.2%), ahead of Other Foreign at $500.00M (12.0%) and United Kingdom at $427.00M (10.2%). The other two regions brought in $402.00M combined.
Compared with fiscal 2016, Other Foreign grew fastest, up 133.6% to $500.00M. Every region above 2% of revenue grew.
CF Industries Holdings began breaking out United Kingdom in fiscal 2015 and North America Excluding United States & Canada in fiscal 2016.
CF Industries Holdings (CF) reports its revenue by segment and by geography. In fiscal 2025, Ammonia was its largest segment, bringing in $2.18B (41.0% of the total), followed by Uan at $2.16B (40.8%).
Ammonia was CF Industries Holdings' largest segment in fiscal 2025, bringing in $2.18B, or 41.0% of the $5.30B total across its four segments.
United States was CF Industries Holdings' largest region in fiscal 2017, bringing in $2.85B, or 68.2% of the $4.18B total across its five regions.
Among CF Industries Holdings' regions that make up at least 2% of revenue, Other Foreign grew fastest in fiscal 2017, up 133.6% from $214.00M to $500.00M.
Every figure comes from CF Industries Holdings' annual financial filings, as reported. Each line keeps the name CF Industries Holdings gives it, and years follow its fiscal calendar.
CF Industries Holdings' revenue by segment goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.